Research.Patient.info

Adult patients with relapsed or refractory aggressive B-cell non-Hodgkin lymphoma research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingTherapeutic confirmatory (Phase III)
Tisagenlecleucel versus standard of care in adult patients with relapsed or refractory aggressive B-cell non-Hodgkin lymphoma: A randomized, open label, phase III trial (BELINDA)
Netherlands · Spain · Norway